William Blair Initiates Coverage on Immunic (NASDAQ:IMUX)
Research analysts at William Blair initiated coverage on shares of Immunic (NASDAQ:IMUX – Get Free Report) in a research note issued to investors on Tuesday, Marketbeat.com reports. The brokerage set an “outperform” rating on the stock. William Blair also issued estimates for Immunic’s FY2025 earnings at ($0.89) EPS. A number of other brokerages have also […]
Research analysts at William Blair initiated coverage on shares of Immunic (NASDAQ:IMUX – Get Free Report) in a research note issued to investors on Tuesday, Marketbeat.com reports. The brokerage set an “outperform” rating on the stock. William Blair also issued estimates for Immunic’s FY2025 earnings at ($0.89) EPS. A number of other brokerages have also […]
